This work reports on the development and testing of an intracranial stereotactic patient positioning system (ISPPS) for Tomotherapy. The ISPPS consists of the combination of a head frame, head frame couch interface (HCI), megavoltage CT (MVCT), and optical tracking camera system. Three quality assurance tests were designed to quantify the positioning system's ability to localize an intracranial target. The first two of these tests were designed to determine (a) the ability of the MVCT to detect a known shift applied to an anthropomorphic phantom and (b) the precision of fixing the phantom to the treatment couch via a head frame and specially designed head frame couch interface. A system verification test, using a phantom and EDR2 film, was used to determine the overall delivery precision through comparison of a measured dose distribution on film to calculated dose. The average net translational difference between a known shift applied to a phantom and that detected by MVCT image fusion was 0.62 mm. Setup reproducibility of the head frame was measured with both MVCT and optical tracking. The frame setup precision was found to be well within 1 mm for translations as well as rotations. A system delivery verification test in phantom using film showed spatial agreement between planned and delivered dose distributions to within 1 mm.
Introduction
Recently, there has been interest in using the TomoTherapy Hi-ART ® system (To-moTherapy, Inc., Madison, WI) for the delivery of intracranial stereotactic radiosurgery (SRS). Due to the large dose per fraction, high dose rate, steep peripheral dose gradients, and proximity to healthy brain tissues, enhanced target localization and patient positioning must be achievable for SRS delivery. These requirements ensure that the delivered dose covers a small stereotactically localized target while sparing neighboring normal tissue whose function must be maintained to preserve post treatment quality of life. Typically, in SRS treatment planning, only the gross tumor volume (GTV) is contoured with no added margins for setup uncertainty. According to the AAPM report of Task Group number 42, the stereotactic localization technique must be cable of localizing a well-defined target, such as a ball bearing, with an overall uncertainty of no more than 2 mm (1). In addition, the mechanical precision of aligning the patient-based, or frame-based, coordinate system with the linac coordinate system should be less than 1 mm.
Achieving this level of accuracy requires the use of an intracranial stereotactic apparatus for patient positioning. Such a system must (a) immobilize the head to Technology in Cancer Research & Treatment, Volume 8, Number 1, February 2009 ensure that patient position is reproduced at the time of treatment from the time that the planning image was acquired, (b) provide a method to reference a diagnostic scan to a stereotactic coordinate system in the room, and (c) provide a way to align the stereotactic coordinates that were used to define the target to the coordinates of the delivery unit with a known accuracy and precision (2). Due to the intra-fractional positioning uncertainty associated with mask systems, an invasive head ring has traditionally been employed in single fraction SRS to ensure safe and effective delivery of high doses to small volumes in the brain. A wide variety of these systems are currently commercially available for use on most radiation therapy delivery systems. Since there are fundamental design differences between conventional linear accelerators and the TomoTherapy Hi-ART ® , a new positioning system has been designed for use with this particular radiation therapy delivery system. The proposed intracranial stereotactic patient positioning system (ISPPS) utilizes the on board imaging capabilities of the treatment unit for stereotactic positioning of the patient's cranium, while intra-fractional patient position stability is guaranteed through rigid attachment of the frame to both the patient's skull and the Tomotherapy treatment couch. In particular, the SRS positioning system developed consists of several components that include: an invasive head frame, a Tomotherapy specific head frame couch interface (HCI), and the on board MVCT image guidance coupled with an optical tracking patient localization system.
In traditional SRS, one maps the stereotactic coordinates determined from the treatment planning image to the in-room stereotactic space by employing a SRS localizer system that has been encoded into the stereotactic treatment planning CT. The premise being that the position of the patient does not change from the time of imaging to the time of treatment because of an invasive head frame that rigidly attaches to a stereotactic couch interface on both the CT scanner and the treatment machine. The system proposed here for Tomotherapy employs an invasive head frame, to guarantee patient position stability from the time of imaging to the time of treatment, and the Tomotherapy specific HCI to allow for fixation of the frame to the treatment machine; however, the external stereotactic localization system is replaced by making use of the online MVCT image guidance, where the mapping from the treatment planning CT to the treatment room is accomplished via image fusion between a planning CT and pretreatment MVCT.
Ideally, in SRS the target localization uncertainty should be governed by the overall imaging uncertainty, which is in turn determined by the voxel size. The slice width used for imaging determines the longitudinal dimension of the voxel, while the in plane dimensions are determined by the field of view divided by the image resolution. Before implementing a SRS program on any delivery unit, detailed knowledge of uncertainties associated with each step of the SRS process, from simulation and treatment planning to delivery, has to be acquired. When combining all of these individual uncertainties into an overall uncertainty, the uncertainty associated with imaging should be the largest entering the equation of error propagation so that imaging drives the entire overall uncertainty. Hence, all other uncertainties have to be less than that associated with the imaging modalities employed for treatment target definition. To determine the cumulative effect of all uncertainties, a system test should be performed to determine the overall dose delivery precision. The clinical applicability of tomotherapy as a delivery method for SRS will be dependent on the proven effectiveness of the positioning system and accuracy and precision of the dose delivery. This paper reports on development and testing of an intracranial stereotactic patient positioning system (ISPPS) for Tomotherapy designed to ensure that the overall achievable positioning accuracy is on the order of the uncertainty associated with the imaging modalities employed for treatment target definition and adequate for stereotactic localization of an intracranial target.
Materials and Methods
Prior to determining the uncertainty associated with the proposed Tomotherapy ISPPS, one has to define the clinical workflow that most effectively uses this combination of hardware and software for the most precise, accurate, and efficient delivery. The following clinical workflow has been determined: On the day of treatment, a head frame is placed on the patient prior to treatment planning imaging. A treatment planning MVCT is obtained during which the patient is positioned on the tabletop of the Tomotherapy unit with the head frame attached to the head frame couch interface. Once the patient is setup on the Tomotherapy couch the initial position of the patient is recorded employing the optical tracking system. After image acquisition, the treatment planning MVCT is cross-correlated with a gadolinium contrast enhanced 3D SPGR T1-w MRI. The treatment targets are determined and a treatment plan is generated. After completion of pretreatment QA, the patient is taken to the treatment machine and positioned on the couch using the patient's initial position as recorded by the optical tracking system at the time of treatment planning MVCT acquisition. The patient is again imaged with MVCT and this post-treatment planning MVCT is cross-correlated to the treatment planning MVCT using automatic fusion. The treating physician verifies results of this fusion on the TomoTherapy Operator's Station. Once the treating physician deems the fusion results acceptable, the fusion adjustments are converted to frame and couch adjustments via software. Pitch, yaw, and translational X-axis adjustments are then applied to the frame, while Y and Z axis shifts are applied to the couch, roll can be corrected auto-matically with the delivery software by changing the gantry start position. (Tomotherapy coordinates conform to the IEC standard.) Adjustments are verified in real time with the camera system and the positioning control panel (PCP). Repeat MVCT could also be used for shift verification but would add considerable time on the table for the patient as compared to referring to the camera system. After the set-up position is verified, the patient can then be treated, the frame can be removed, and the patient can be released. The pre-treatment MVCT will quickly indicate possible slippage of the head frame. If the head frame has not slipped between the treatment planning and the post-treatment planning imaging session only minimal adjustments should be required at the time of SRS treatment to realign the patient on the delivery unit.
All testing was performed on a current production model of the TomoTherapy Hi-Art II ® unit with the original couch design. The Operator's Station software was modified to include an interface to support the camera system, and to produce repositioning settings suitable for the HCI and treatment couch based on the image fusion.
CT Localization
In order to reduce the uncertainty associated with MVCT imaging a prototype helical Thin Slice MVCT mode was employed. The MVCT parameters vary from the current production units in that a thinner jaw setting was employed, resulting in a beam width (full-width at half-maximum) that is reduced by three millimeters at isocenter. Couch speeds were maintained at 4 mm per rotation for the "fine" mode acquisition and images were reconstructed at 2 mm intervals. Although the scan speed, image intervals, and imaging dose are virtually unchanged from current production TomoTherapy systems, the smaller jaw setting yields thinner images and sharper sagittal/coronal images (3, 4) . Figure 2a shows a sagittal and coronal view of a head phantom with the normal jaw setting on production units, and Figure 2b shows the same views of the phantom with the thinner jaw settings used in this study. There is a noticeable improvement in the resolution in the craniocaudal direction for the images in Figure 2b , allowing improved registration, whether manual or automatic, in the longitudinal direction. The use of MVCT for target localization using the current system has been described elsewhere (5) (6) (7) (8) (9) .
Mechanical Fixation
In this study, phantom immobilization is accomplished through the use of the 3D Line Stereotactic Invasive Frame (3D Line Medical Systems, Milano, Italy), which is used in conjunction with the specially designed TomoTherapy stereotactic headframe couch interface. The HCI is currently being developed to allow for positioning of the head frame on the top of the couch as opposed to over the end of the couch, where delivery is not possible on the Tomotherapy unit. It is intended to work with a number of commercially available frames. The prototype device has adjustments for both lateral shifts (X-direction) as well as pitch and yaw. It is important to note that the purpose of this device is to keep the patient still throughout imaging and treatment and fixed to the Tomotherapy treatment couch while allowing for the ability to apply precise adjustments indicated by the image guidance. The frame system does not establish the 3D coordinate system as in other stereotactic positioning systems.
Optical Guidance
Optical guidance is performed through the use of an infrared based optical tracking system 3D Line DynaTrac (3D Line Medical Systems, Milano, Italy). Use of this system has been reported elsewhere (10). The system consists of three infrared cameras that are connected to a control computer. Real time tracking of the patient position, in the SRS application, is accomplished by placing four or more passive infrared markers on the head frame that act as surrogates for the patient. Prior to use, the system was calibrated using the manufacturer's two-step procedure. In the first step, a set of markers that are in a very precisely known geometry are used to align the cameras and calibrate the relative distances in an arbitrary 3D coordinate system. In the second step the X, Y, and Z coordinates in the room are related to the camera coordinate system using another set of markers in a phantom with marks that can be aligned to room lasers. The real time 3D deviations of the markers are determined by applying a reconstruction algorithm to the 2D images of the reflectors obtained by the three infrared cameras. The camera system calculates both translations and rotations and can detect the position of a well-defined optical probe consisting of a number of markers to an accuracy of 0.1 mm and 0.1 degrees Use of optical tracking for patient localization has been described in detail by several authors (10-12).
Experimental Methodology
The testing methods employed here are based on tests described by Tomé and colleagues at the University of Wisconsin for the commissioning and quality assurance of an optically guided three-dimensional ultrasound target localization system for radiotherapy (11). The procedure introduced in their work can be applied to any image-guided delivery system and was also successfully utilized by Boswell et al. for validation MVCT for localization in the special case of an anthropomorphic head phantom (13). Since we are trying to determine the absolute accuracy of the Tomotherapy Hi-Art system for SRS, it is important to establish a consistent in room 3D coordinate system. As in the aforementioned studies, the coordinate system was established here through the use of an optical tracking system. Hence, the position predictions of all components are compared relative to the positions measured by the optical tracking system.
The piecewise testing of the entire system's targeting abilities proceeded as follows. First, the agreement of the MVCT automatic fusion with the optical tracking system was determined. Second, the precision of the mechanical immobilization device consisting of the minimally invasive head frame and HCI was investigated. Finally, a system verification test was performed to determine the precision of the final dose delivery using the proposed ISPPS.
MVCT Autofusion Procedure
All MVCT images were taken using the thin slice setting described earlier to provide improved longitudinal resolution. It was determined that, for the special case of the head-phantom used in this study, an iterative sequence of fusion operations yielded a parameter-set which converged to a stable solution. The auto fusion algorithm was run sequentially 4 times for each MVCT scan. Manual fusion corrections were not employed so the results were independent of the skill of the operator. However, the accuracy of the fusion was reviewed by the operator to identify any gross errors; none were observed. For the first of the four fusions, the "Bone and Tissue" technique was used with the "Standard" resolution and all six corrections, "Translations + Pitch + Yaw + Roll" for the initial alignment. The subsequent three fusions were the same except used the "Superfine" resolution to get a fine fusion adjustment. The resolution here has to do with how many pixels are used for the fusion. On "Standard" the image is downsampled 4 times in the right-left and anterior-posterior directions before fusing. For "Fine", it is downsampled 2 times in the same directions. For Superfine, there is no downsampling and all voxels are used for the autofusion. The time for the autofusion to complete increases with the number of voxels, so it is best to get a coarse adjustment first by using standard resolution before moving to superfine resolution.
The autofusion algorithm used by Tomotherapy has been described elsewhere (13, 14) . Briefly, the difference between the techniques has to do with voxels that are considered in the fusion. Full images uses a Mutual Information technique with no thresholding so all voxels are used. Bone technique uses a technique described by Ruschala (14) as extracted feature fusion (EFF) that only uses voxels with a density value above 1.1 g/cm 3 , typical bone density, for the fusion. The Bone and Tissue technique uses only voxels with density values greater than 0.3 g/cm 3 , to include both soft tissue and bone density. The latter technique was used for all scans of our anthropomorphic phantom.
Part A: Localization Accuracy of MVCT Fusion
First, the ability of the automatic fusion algorithm to precisely determine known offsets applied to the phantom was tested. The camera, which here is the gold standard for exactly determining the phantom position, was used to measure the position of the phantom after the nominal offsets were applied using the couch. Shifts indicated via MVCT were compared to these known offsets measured with the camera.
Testing proceeded as follows. The CIRS Radiosurgery Head Phantom model 605 (CIRS, Inc., Norfolk, VA) was mounted in the head frame using titanium-tipped screws with all adjustments set to zero (Fig.1) . The position of the phantom head frame complex was recorded using the optical tracking system. An initial MVCT was acquired and registered to a kVCT planning image. The registration parameters were transferred to the camera, couch, and HCI to align the phantom. The optical tracking system was used to verify that the repositioning was performed correctly. A second MVCT was also acquired and registered to the planning image to confirm the registration parameters were nominally zero. With the phantom aligned to the planning CT image, known shifts were then applied to the phantom. Set-up positions were predetermined and given a unique "Set-up ID" so that position 1, for example, corresponds to a particular position as determined by the camera. The five positions were applied randomly. In the 22 trials, each setup ID was repeated 3-6 times depending on the frequency it appeared in the randomly generated sequence. The nominal offsets for each position are shown in Table I . Setting up to different locations gives the fusion algorithm different starting points for the image registration. After inducing the shift, a MVCT of the phantom was acquired and then registered with the original planning image using the standard six-parameter iterative fusion process described earlier. All six registration parameters were recorded. The phantom was then set to another one of the five positions and the process was repeated. The operator carrying out the image fusion was blind to the induced shift to remove any bias in the image fusion. Pitch, Yaw, and Roll were recorded to reproduce the standard procedure used throughout this work and to verify that that phantom was not accidentally bumped during the experiment.
Part B: Precision of Resetting the Head Frame in the Tabletop Interface
After determining the agreement of the camera system with the registration, the reproducibility of setting the frame in the HCI under the aid of optical guidance was determined. The aim was to determine the accuracy of the HCI and couch controls to set the phantom to a known position determined by the camera and quantify the precision of resetting the head frame in the holder. The position of the frame is altered with controls located on both the HCI and the PCP on the treatment unit. Pitch, Yaw, and the X translation are handled by controls on the HCI, Y, and Z translations are controlled by the Tomotherapy couch controls. Roll is corrected automatically by the treatment machine and not handled by any of these components. By setting up the frame repeatedly, the precision of this set-up could be quantified. MVCT was used to determine the ability of repeatedly setting up the frame based on the mechanical dials and optical guidance.
Testing began with the acquisition of a CT image set of the phantom and head frame for treatment planning. For the purpose of this work, a kVCT data set instead of a MVCT data set was employed as the reference CT image set on the treatment unit. The phantom and head-frame were mounted to the Tomotherapy couch and a post-treatment planning MVCT image was acquired. The post-treatment planning MVCT was registered to the planning image using the standard 4-run fusion procedure and the adjustment parameters were sent to the couch, HCI, and camera. After re-positioning, another MVCT was acquired to verify the alignment with the original planning image. Additionally, the HCI and couch settings were recorded. The baseline dial positions were then determined to be 20.69 for the X position, 20.85 for the pitch, and 2.39 for the yaw, in arbitrary dial units. The couch positions were 393.4 mm in the Y direction and 388.4 mm in the Z direction.
After the initial positioning was determined, the headframe was taken out of the HCI. The HCI adjustments were set to zero, and the "slew mode" on the PCP was used to move the couch (Y and Z) a random distance of about 5 cm. The head frame was then reattached to the HCI and the HCI and couch positions were set back to the values recorded after the initial registration. At this point, the camera system was checked for agreement and used for further fine adjustments of the couch to account for mechanical limitations in the couch mechanism. These adjustments were typically less than 0.5 mm from the recorded value, and all were under the nominal 1 mm accuracy of the couch. Next, the phantom was imaged again and the standard 4-run fusion procedure was performed. The constancy of the fusion results was then quantified to provide an indication of the set-up reproducibility. Camera readings were taken both upon initial set up of the phantom and immediately after MVCT fusion. The camera readings shown in Table III are an average of these two readings that are thought to best represent the position at the time of MVCT scanning. These results point to the ability of the mechanical adjustment to return the camera values to zero. Deviations from zero show the combined limitation of the head holder and couch controls to set the phantom to a particular location.
Part C: Dose Delivery Verification
The ultimate test to determine if dose can accurately be delivered as planned is comprehensive delivery quality assurance where the entire procedure is completed start to finish and the delivered dose distribution is measured and compared to the calculated dose.
Delivery verification was performed using the Lucy ® 3D QA phantom (Standard Imaging Inc., Middleton, WI). This phantom is a spherical Lucite phantom that can be rigidly attached to the 3D-Line frame via a frame specific adaptor. One of the unique features of the phantom is the ability to replace portions of the internal structure of the phantom without disturbing its location in the treatment system. In this experiment, a mineral-oil filled "structure insert" was used for planning and to provide objects for the registration algorithm. For dosimetry, the structure insert was replaced with an identically sized film-holder. This allowed the measurement of dose in the same location that was used for registration.
To begin the procedure, a kVCT was taken of the Lucy phantom containing the mineral-oil filled "structure insert". Contours were then drawn around the three mineral-oil containing regions. A plan was created to treat two of the contoured volumes with the other one used as a region at risk (Fig. 3) . The phantom was set up in the 3D Line adaptor and, mounted to the HCI, and an MVCT was acquired. Because of the mostly uniform contents of the Lucy phantom and the relatively small fractional volume of the structure insert, an initial approximate manual registration using X, Y, and Z shifts was required to align the MVCT to the KVCT before the standard 4-run fusion process would correctly align the regions in the volume insert. The registration adjustments were applied to the HCI and couch and then verified with the camera system. An MVCT was acquired again to double-check the repositioning.
Kodak EDR2 Film (Eastman Kodak Company, Rochester, NY) was cut to fit into the film cassette and placed in the phantom. A film calibration was performed with the tomotherapy system a few weeks prior to testing. The prescribed dose was delivered to the phantom. Films were processed, scanned, and saved in the Tomo Film Analyzer software. The standard Tomotherapy delivery quality assurance (DQA) process was used to determine the position of the delivered dose as compared to the planned dose. In this process, dose is delivered to the phantom with the film located in a transverse plane within the planned dose distribution, replacing the mineral oil inserts, and irradiated with the planned treatment. The film was registered to the image of the phantom with the film-holder installed that was used for the DQA dose calculation. The "General Transverse" registration method was employed, which could determine the film position relative to the phantom by aligning the CT visible tungsten pins in the film-holder and the puncture marks they made on the film. Film density was scaled appropriately due to minor differences in processing conditions between the time of the film calibration and the actual test. Relative dose distributions were compared by registering planned and calculated isodose distributions and comparing a sampling of measured versus calculated dose profiles across various regions of the film. Gamma analysis was preformed using criteria of 1 mm distance to agreement and 3% dose difference to determine the precision of the delivery. The criteria were chosen to allow for a smaller margin for set-up uncertainty as compared to conventional planning. An absolute dose measurement was not taken at this time due to the fact that we were mostly concerned with the location of the dose distribution with respect to the phantom than the actual magnitude of the dose to the target. Film was a suitable dosimeter for this purpose.
Results

Part A: Results for Localization Accuracy of MVCT Fusion
To test the accuracy of the registration of the MVCT to the planning image, the difference between the fusion results and known induced displacements was calculated for each trial. Results are shown in Table II . Error is reported as the standard deviation for the differences measured along each axis and the net displacement (calculated for each trial as the root mean square of the X, Y, and Z differences). The standard deviation of the difference between the fusion-measured offsets and the induced offsets is 0.21 mm, 0.30 mm, and 0.20 mm in the X, Y, and Z directions, respectively, with a net displacement of 0.22 mm. These errors are smaller than the voxel size of both the MVCT (0.78 mm × 0.78 mm × 2 mm) and the kVCT (1.4 mm × 1.4 mm × 1.2 mm). This result is expected due to the overdetermined nature of the registration calculation that fits six parameters using data from two very large image volumes with many features and the interpolation applied to the MVCT image during the fusion process. Pitch, yaw, and roll were not intentionally changed in this experiment, and the camera values for all trials were zero. The standard deviations of the fusion adjustments minus the measured parameters are also near zero at: 0.11º, 0.05º, and 0.07º for pitch, roll, and yaw, respectively.
In addition to the standard deviations reported above, the average difference across all trials was also calculated the results are 0.19 mm, 0.30 mm, and 0.51 mm for X, Y, and Z, respectively, with a net displacement of 0.68 mm. Results were -0.09º, -0.56º, and 0.02º for pitch, roll, and yaw. Note that there was no roll correction applied in these experiments, so that value is not expected to be zero but should have zero standard deviation. Similarly, the other difference values are likely due to errors in the initial setup and not related to the registration trials.
Part B: Results of Precision of Setting the Frame in the Tabletop Interface
Results of the setup up reproducibility of the head frame and using the HCI, couch, and camera were quantified by measuring MVCT fusion constancy on repeat setup of the frame. The frame was set up 12 times with one trial excluded due to experimental error. Results are shown in Table III . Average translational fusion adjustments on MVCT for the 11 repeated set-ups that were included were 0.55 mm, 0.25 mm, 0.30 mm in the Lateral Longitudinal and Vertical directions, respectively, with and average net displacement of 0.67 mm. Pitch, roll, and yaw changed by an average of -0.06º, -0.94º, and 0º, respectively. These results show the accuracy of the set-up by comparing the actual position to the expected position. Precision is indicated by standard deviations of the fusion results, which were 0.07 mm, 0.28 mm, 0.17 mm, 0.10º, 0.06º, and 0.05º for the lateral, longitudinal, vertical, pitch, roll, and yaw adjustments, respectively. These results show acceptable variation in head frame position upon repeat set up using the HCI and couch controls with the camera to indicate position and MVCT to measure deviations from the planned position.
Table III also shows the average of two camera readings in each fusion direction for all trials as described earlier. These small changes in camera position show the limitations in the mechanical couch and frame adjustments. The final camera readings for the 11 included trials varied from the expected zero reading by averages of 0.01 mm, 0.13 mm, 0.06 mm in the Lateral Longitudinal and Vertical directions, respectively. Pitch, roll, and yaw changed by an average of -0.05º, 0º, and -0.06º, respectively. Standard deviation of 0.13 mm, 0.28 mm, 0.15 mm, 0.09º, 09º, and 0.07º in the lateral, longitudinal, vertical, pitch, roll, and yaw.
Part C: Results of Delivery Verification
Delivery verification was performed by creating a treatment plan on the Lucy ® phantom (Fig. 3) , setting the phantom up on the couch with our designated ISPPS and workflow, and delivering the plan to the phantom with a film inserted into the high dose region. The results were analyzed using the TomoTherapy Film Analyzer software that shows relative dose distributions and compares measured versus delivered dose on any horizontal, vertical, or diagonal profile. As show in Figure 4 , on visual inspection there is an acceptable match between the planned and measured isodose distributions. The profile comparison shows agreement between the measured and delivered dose of less than a millimeter. As a more quantitative measure of the comparison, a gamma index was used as described by Low et al. (15) . The gamma was calculated so that a gamma value equal to 1 corresponds to an agreement of 3% dose difference with an allowable 1 mm distance to agreement. The TomoTherapy Treatment Planning software can calculate and display gamma maps using any dose difference and difference to agreement criteria. The gamma map for the film used here is shown in Fig- ure 5. Points shown with a value of 1 or less fit our criteria.
The image shows good agreement between the measured film plane and the calculated dose to within the 3% dose difference and 1 mm distance to agreement criteria. A gamma histogram shows that less than 1 percent of the points in our area of interest, which included the two areas under treatment and all but a small margin around the film, exceeded a Gamma value of one with less than 15% exceeding a value of 0.5. In other words, the majority of points easily achieved our criteria indicating acceptable delivery precision. This analysis was only meant to show the relative location of the delivered dose distribution, an absolute dose comparison will be included in a future publication.
Discussion
As a result of this investigation, we believe the following workflow will result in accurate and precise localization of a target for intracranial SRS. After placement of the head frame, a treatment planning MVCT is obtained during which the patient is positioned on the tabletop of the Tomotherapy unit with the head frame attached to the HCI.
Once the patient is setup on the Tomotherapy couch, the initial position of the patient is recorded employing the optical tracking system. Next, treatment targets are determined and treatment planning is carried out. After completion of pretreatment QA, the patient is taken to the treatment machine and positioned on the couch using patient's initial position as recorded by the optical tracking system at the time of treatment planning MVCT acquisition. The patient is then imaged with the on board imaging system and the imaging data is reconstructed to create a high resolution MVCT image set. The MVCT image is fused to the planning MVCT image set via the automatic fusion algorithm using the bone and tissue technique with superfine resolution. After approval of the fusion results by the treating physician, adjustments are applied to the couch and HCI to move the patient to the correct location with respect to the machine coordinates. Adjustments are then verified and fine tuned with the use of the optical guidance system. After this verification, the patient can be treated.
Although delivery of SRS using Tomotherapy has not become routine at many sites, the system does have some features that can be exploited to allow for safe, effective, and efficient delivery of large doses in a single fraction; the main advantage being the on board imaging system, where the treatment linac doubles as an imaging source. This design feature allows for a shift in the way one thinks about the requirements for stereotactic localization because one is no longer blind to the location of the target with respect to the external anatomy at the time of treatment delivery and the risk of a geographic miss of the target is minimized. According to AAPM task group 68, if the initial coordinates are CT based then "repeat CT scanning provides the most basic indication or repositioning accuracy" (2). The entire head can easily be included in the scan so one does not have to worry about proximity of targets to various landmarks. MVCT is generally not subject to geometric distortion but this should be tested prior to implementation. Although not currently available, it is possible that MVCT quality and fusion accuracy could improved by not only using a thinner jaw for imaging but also changing the image reconstruction to allow for a minimum reconstruction interval of 1 mm as opposed to the 2 mm currently available. This addition should improve the resolution and fusion performance in the longitudinal direction over the currently available system and is presently being investigated.
Tomotherapy simplifies the stereotactic process and potentially allows for a stereotactic option at tomotherapy sites that do not have a dedicated, or radiosurgery-capable, delivery system. SRS is easy to implement because the workflow is similar to day-to-day treatments on Tomotherapy. The only required additions are essentially a more robust immobilization device and a camera system.
The ISPPS as a whole achieved precise and accurate set up and localization with mechanical fixation and image guidance. Anatomical coordinates are tied to machine coordinates via the MVCT. These are then tied to the treatment planning system via image fusion. The camera system provides an in-room coordinate system that serves to show real time vector displacements of the patient from the original position during patient set-up. The actual coordinates are unimportant but the difference in coordinates from one point in time to another are of interest. The advantage of the camera is that it can determine this change in position very precisely and in real time without requiring additional procedure time and unnecessary imaging exposure to the patient.
In contrast to more conventional stereotactic localization techniques, no external coordinate system needs to be encoded into the treatment planning CT to allow for the stereotactic localization of treatment targets. Since the Hi-Art system allows for non-isocentric treatment delivery, it is possible to treat multiple targets within in the cranium in one treatment with no need for multiple isocenters. A head frame however is still required to guarantee that the target positions are conserved from the time of the acquisition of the planning MVCT to the time of treatment delivery and to ensure positional stability over the course of treatment delivery. A head frame is the ideal immobilization device since it is rigidly attached to the patient's skull ensuring that the position of the skull, in relation to the treatment beam, remains constant over the course of treatment. The adjustments on the frame are only needed to provide a coarse adjustment to reproduce the patient's positioning at simulation at the time of treatment and to provide precise adjustments to correct for any error detected by the imaging system. The actual dial setting need not be exactly the same at the time of CT and delivery.
In order to get around issues of couch sag differences between the Tomotherapy couch and the CT couch when treating various targets distributed throughout the cranium, as is the case for patients having multiple brain metastases, we have proposed the use of a thin slice MVCT image set for treatment planning since the correct couch sag is encoded into this image set. It has been shown that use of the MVCT for treatment planning yields accurate dose computation results (9). The main limitation of using the MVCT has traditionally been image quality. Investigation of performance characteristics resulting from the aforementioned modifications to the MVCT, including the thinner imaging jaw width and 1 mm reconstruction interval, are currently underway at TomoTherapy, Inc. Initially this could reduce the MVCT voxel size to 1.56 mm × 1.56 mm × 1 mm for treatment planning. It is expected that image quality will be improved with these alterations making it more comparable to kVCT image quality and reducing the voxel size to become adequate for treatment planning. Imported MVCTs for planning will therefore have a voxel size of 1.56 mm × 1.56 mm × 1 mm, which is comparable to conventional kVCT images used for tomotherapy, and appropriate for SRS planning. In plane pixel dimensions will still be twice as large as those used in many conventional SRS planning systems that are capable of dose calculations on 512 × 512 resolution images and it will be important to keep this in mind when considering Tomotherapy for very small targets, since the image resolution determines the smallest possible dose voxel size. In addition, target delineation in SRS is usually accomplished using volumetric MRI that can easily be fused to the MVCT for contouring while the MVCT can provide the density information for the dose computation. For dose calculation, it would be only be required that an image value to density table is created for the tomo unit and extensive MVCT QA procedures are implemented to ensure the constancy of the CT numbers as well as check for the integrity of the image quality, including spatial resolution and artifacts.
In summary, the intent of this work was to determine the accuracy and precision of a proposed image guidance based localization system to allow for stereotactic radiosurgery delivery using helical tomotherapy. The proposed system combines a minimally invasive head frame and head frame couch interface for mechanical fixation, the unit's own MVCT for stereotactic localization, and an optical guidance system for real time patient tracking during treatment and for fusion adjustment verification. Using this combination of hardware and software, which has self-contained redundant checks of the patient's position, it was determined that sub millimeter set-up accuracy can be achieved for an anthropomorphic head phantom.
